Case report of Klinefelter's syndrome with severe diabetes, dyslipidemia, and stroke: The effect of pioglitazone and other anti-inflammatory agents on interleukin-6 and -8, tumor necrosis factor-alpha, and C-reactive protein.
Yoshiuchi
Issei
I
Itoh
Naoto
N
Nakano
Misa
M
Tatsumi
Chikao
C
Yokoyama
Kenji
K
Matsuyama
Tatsuo
T
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000378:metabolism; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D050171:Dyslipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D016209:Interleukin-8 / Q000097:blood; D007713:Klinefelter Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D000077205:Pioglitazone; D020521:Stroke / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D045162:Thiazolidinediones / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D000893:Anti-Inflammatory Agents; D015850:Interleukin-6; D016209:Interleukin-8; D045162:Thiazolidinediones; D014409:Tumor Necrosis Factor-alpha; D002097:C-Reactive Protein; D000077205:Pioglitazone